Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial

PHASE2TerminatedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Ischemic Stroke
Interventions
DEVICE

Intra-arterial Clot Retrieval with Solitaire device

Intra-arterial mechanical clot retrieval with the Solitaire device after patients have received standard therapy with intravenous tissue plasminogen activator (tPA). Clot retrieval involves cerebral angiography and takes approximately 2 hours.

GENETIC

intravenous tissue plasminogen activator (tPA)

Standard care IV tPA therapy administered as per registered product information

Trial Locations (9)

1001

Auckland Hospital, Grafton

2305

John Hunter Hospital, New Lambton Heights

2605

Royal North Shore Hospital, St Leonards

3011

Western Hospital, Melbourne

3084

Austin Hospital, Melbourne

3128

Box Hill Hospital, Melbourne

3168

Monash Medical Centre, Melbourne

5000

Royal Adelaide Hospital, Adelaide

Unknown

Royal Melbourne Hospital, Melbourne

Sponsors
All Listed Sponsors
lead

Neuroscience Trials Australia

OTHER

NCT01492725 - Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial | Biotech Hunter | Biotech Hunter